Jason Dean

Head Of Bioinformatics at Tune Therapeutics

Jason Dean has worked in the field of bioinformatics for over 18 years. Jason began their career as a Graduate Student Researcher at UCLA in 2003. In 2010, they moved to Amgen as a Postdoctoral Research Fellow. In 2011, they were hired as a Senior Scientist - Expression at Merck Research Labs. Jason then moved to Matrix Genetics in 2013 as a Senior Research Scientist. In 2017, they joined Bellwether Bio as a Senior Scientific Programmer. In 2019, they were hired as a Senior Bioinformatics Scientist at Guardant Health. In 2020, they became a Principal Data Scientist at Shape Therapeutics Inc. and most recently, in 2022, they were appointed as the Head of Bioinformatics at Tune Therapeutics.

Jason Dean received a Bachelor of Science in Chemical Engineering from the Georgia Institute of Technology in 2003. Jason then went on to receive a PhD in Chemical Engineering from the University of California, Los Angeles in 2009.

Location

Seattle, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Tune Therapeutics

1 followers

With its versatile and powerful TEMPO epigenomic control platform, Tune Therapeutics is pioneering a new therapeutic modality that can fine-tune any gene network and unlock the full power and potential of regenerative medicine. With deep experience and a passionate commitment to exploration and innovation, Tune is driving through an inflection point in the history of genetic medicine: from targeting a limited range of rare conditions, to addressing thousands of common and complex diseases for which no curative treatment is available.


Employees

51-200

Links